Anti-Cancer Natural Products and Their Bioactive Compounds Inducing ER Stress-Mediated Apoptosis: A Review.
Kim C, Kim B. · 2018
Read Anti-Cancer Natural Products and Their Bioactive Compounds Inducing ER Stress-Mediated Apoptosis: A Review. by Kim C, Kim B. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6115829.txt.
Introduction
Kim and Kim wrote a review in Nutrients on natural products that kill cancer cells through stress in the endoplasmic reticulum. The endoplasmic reticulum folds proteins inside cells. Tumor conditions can strain it and pile up unfolded proteins. Cells first try to adapt to that stress. If it lasts, they can be pushed to die.
The review explains how this stress leads to cell death. It then surveys plant and other natural compounds that use this route. The survey covers six major cancers, from lung to liver. Blocking the adaptive response is one proposed tactic. Pushing the death response is another.
Catalog record
| CREATOR | Kim C, Kim B. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 82 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Anti-Cancer Natural Products and Their Bioactive Compounds Inducing ER Stress-Mediated Apoptosis: A Review By Changmin Kim, Bonglee Kim Published in: Nutrients DOI: 10.3390/nu10081021 ABSTRACT Cancer is the second biggest cause of death worldwide. Despite a number of studies being conducted, the effective mechanism for treating cancer has not yet been fully understood. The tumor-microenvironment such as hypoxia, low nutrients could disturb function of endoplasmic reticulum (ER) to maintain cellular homeostasis, ultimately leading to the accumulation of unfolded proteins in ER, so-called ER stress. The ER stress has a close relation with cancer. ER stress initiates unfolded protein response (UPR) to re-establish ER homeostasis as an adaptive pathway in cancer. However, persistent ER stress triggers the apoptotic pathway. Therefore, blocking the adaptive pathway of ER stress or facilitating the apoptotic pathway could be an anti-cancer strategy. Recently, natural products and their derivatives have been reported to have anti-cancer effects via ER stress. Here, we address mechanisms of ER stress-mediated apoptosis and highlight strategies for cancer therapy by utilizing ER stress. Furthermore, we summarize anti-cancer activity of the natural products via ER stress in six major types of cancers globally (lung, breast, colorectal, gastric, prostate and liver cancer). This review deepens the understanding of ER stress mechanisms in major cancers as well as the suppressive impact of natural products against cancers via ER stress. 1. INTRODUCTION Cancer is a group of diseases that undergo unregulated cell growth and proliferation without stopping [1]. Although overall survival term is increased slightly due to early detection, cancer-related mortality is the second biggest cause of death worldwide [2]. The International Agency for Research on Cancer (IARC) reported that 14.1 million new cancer cases and 8.2 million deaths took place worldwide in 2012, and 21.7 million cancer incidences and 13 million deaths were predicted in 2030. Among several types of cancers, lung, breast, colorectal, gastric, prostate, and liver cancer were selected as the major cancers in human being. These cancers represent 55% of the global cancer incidence burden in 2012 [3]. The mechanisms of cancer occurrence and progression are not fully understood yet. The proliferation of cancer originated from its ability to avoid programmed cell death, so-called apoptosis [4]. That is why induction of apoptosis in cancer has been identified as a target for treatment of cancer [5,6]. Up to now, induction of apoptosis is conducted by two main apoptotic pathways: intrinsic and extrinsic pathway [7]. Intrinsic pathway is mitochondria-mediated apoptosis which is mediated by cytochrome C release and activation of caspase-9, stimulating effector caspases, caspase-3. Extrinsic pathway is death receptor (DR)-mediated apoptosis which activates the FAS-associated death domain (FADD) and forms the death-inducing signaling complex (DISC), which processes downstream caspases including caspase-8,-7,-6, and -3 [8,9]. However, studies have identified that the accumulation of unfolded proteins in endoplasmic reticulum (ER) and its cellular stress response is involved in apoptosis, indicating influence of ER on cell fate as a third subcellular compartment [10]. Overview of ER Stress; A Double-Edged Sword-Cell Survival or Death? ER is an organelle in the eukaryotic cell that is responsible for protein synthesis and calcium (Ca2+) signaling [11]. It also provides a suitable environment for lipid, steroid, and cholesterol biosynthesis. Moreover, the main roles of ER include maintenance of homeostasis in intracellular Ca2+ storage and the folding of protein destined to be secreted on the plasma membrane [12]. Proteins are translocated into ER lumen and undergo post translational modification for fidelity of synthesis, folding and correcting function. After passing ER, proteins are properly folded by a network of chaperones [13]. However, extra-cellular environmental challenges such as reactive oxygen species (ROS), hypoxia, and nutrients deprivation could induce disturbance in cellular redox regulation of ER, leading to an imbalance in homeostasis. Thus, the physiological function of ER and the ER protein-folding environment are impaired, ultimately resulting in the accumulation of unfolded protein in the lumen of the ER-namely, ER stress [10]. Prior studies have demonstrated that both ER stress and the activation of unfolded protein response (UPR) are associated with pathologic processes, including neurodegenerative diseases, cardiovascular disease, and cancer [14]. Because of the rapid expansion of malignant neoplasm, cancer cells are exposed to low nutrients, poor vascularization, and hypoxia so that ER stress-related proteins including glucose-regulated protein 78 (GRP78)/binding protein (BiP), glucose-regulated protein 94 (GRP 94), ER associated degradation (ERAD), protein disulphide isomerase (PDI), activating transcription factor 6 (ATF6), inositol-requiring protein 1 (IRE1), α-x-box binding protein 1 (XBP1), protein kinase RNA-like ER kinase (PERK) and eukaryotic initiation factor 2 (eIf2α) are overexpressed in many types of cancer cells [15,16,17]. In response to ER stress on early phase, the cell initiates UPR to modulate proper protein folding and degradation of unfolded protein as an adaptive pathway for survival. Under ER stress, GRP78/BiP, which originally binds to the luminal domain of three ER transducer sensors: IRE1, PERK, and ATF6, dissociates from these three ER transducer sensors. The three ER-localized transmembrane signal-transducers of UPR; ATF6, IRE1 and PERK detect accumulation of unfolded proteins and initiate to restore and maintain the ER homeostasis [18]. Moreover, ERAD is increased to attenuate unfolded protein accumulation, enhancing protein folding capacity in ER and ER chaperones (GRP 94, GRP78/BiP, calnexin), which are elevated to stabilize protein folding. However, if ER stress is prolonged to the extent that UPR is unable to cope with unfolded proteins, UPR is promoted to be turned into apoptotic machineries by transducing apoptotic downstream pathways through ATF6, PERK, and IRE1 signaling pathways [19]. 2. ANTI-CANCER STRATEGY BASED ON ADAPTIVE PATHWAY OF ER STRESS IN CANCER GROWTH Cancer cells evolve UPR to mitigate the ER stress condition as a survival strategy for progression [20]. Also, UPR in cancer is reported to have significant roles in having resistance to chemotherapy or radiation [17,21]. Therefore, one therapeutic rationale regarding suppression of cancer is to facilitate the accumulation of unfolded proteins by inhibiting components of UPR involved in survival response, ultimately leading to apoptosis [22] (Figure 1). 2.1. Anti-Cancer Strategy; Targeting ATF6α-GRP78/BiP Signaling A first modulator of ER stress signaling is ATF6α-GRP78/BiP. During ER stress conditions, dissociation of GRP78/BiP from ATF6 allows this protein to translocate to Golgi apparatus where it is cleaved by specific Golgi resident proteases [23]. This process forms ATF6α, which produces active transcription factors that are involved in up-regulating ER chaperones and ERAD [24]. In addition, ATF6α contributes to transcription factor XBP1, which targets the ERAD [25] (Figure 1). Further, the expression of GRP78/BiP is elevated particularly in liver, colon, prostate, breast, lung, and gastric cancer [26,27,28]. The elevated expression of GRP78/BiP is reported to correlate with cancer proliferation, chemotherapy resistance, and poor patient survival rate by modulating accumulation of unfolded protein folding [29,30,31]. In addition, GRP78/BiP induces angiogenesis by activating the potent pro-angiogenic factor, vascular endothelial growth factor A (VEGF-A) [32]. Recently, studies have confirmed that knockdown of GRP78/BiP by siRNA can inhibit carcinogenesis and sensitize cancer cells to chemotherapeutic agents as well as ER stress [33,34,35]. The GRP78/BiP inhibitor exerted cytotoxicity against leukemia [36] and glioma cancer cells [34]. These observations suggest that during ER stress, inhibition of the ATF6-GRP78/BiP signaling pathway could be a strategy for cancer therapy [37]. For example, the knockout of GRP78 resulted in decreased proliferation rates of glioma cells and suppressed PTEN null